| Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer (NCT07747740) | Blokhin's Russian Cancer Research Center | 2026-07-09 |
| Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers (NCT07464470) | Blokhin's Russian Cancer Research Center | 2026-04-01 |
| Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer (NCT07448493) | Blokhin's Russian Cancer Research Center | 2026-02-01 |
| Local Treatment Strategies for Brain Metastases of Colorectal Cancer (NCT07448662) | Blokhin's Russian Cancer Research Center | 2026-02-01 |
| A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients (NCT07281001) | Blokhin's Russian Cancer Research Center | 2025-12-01 |
| Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer (NCT07107217) | Blokhin's Russian Cancer Research Center | 2025-08-01 |
| Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers (NCT07542262) | Blokhin's Russian Cancer Research Center | 2025-06-03 |
| Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy (NCT07633236) | Blokhin's Russian Cancer Research Center | 2025-03-28 |
| A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer (NCT06978400) | Blokhin's Russian Cancer Research Center | 2025-03-01 |
| A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer (NCT06967155) | Blokhin's Russian Cancer Research Center | 2025-03-01 |
| Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer (NCT06449989) | Blokhin's Russian Cancer Research Center | 2024-04-01 |
| A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors (NCT06355921) | Blokhin's Russian Cancer Research Center | 2024-04-01 |
| Neoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal Cancer (NCT07523763) | Blokhin's Russian Cancer Research Center | 2024-03-22 |
| Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection (NCT05939687) | Blokhin's Russian Cancer Research Center | 2023-06-05 |
| The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer (NCT05547529) | Blokhin's Russian Cancer Research Center | 2022-09-14 |
| Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer (NCT06428487) | Blokhin's Russian Cancer Research Center | 2022-03-31 |
| Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy (NCT05057195) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors (NCT05057143) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors (NCT05057130) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy (NCT04928365) | Blokhin's Russian Cancer Research Center | 2021-03-25 |
| Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. (NCT04852081) | Blokhin's Russian Cancer Research Center | 2021-01-01 |
| FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (NCT04442984) | Blokhin's Russian Cancer Research Center | 2019-11-03 |
| Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer (NCT04135313) | Blokhin's Russian Cancer Research Center | 2019-10-20 |
| Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer (NCT04134897) | Blokhin's Russian Cancer Research Center | 2019-10-14 |
| Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) (NCT04055038) | Blokhin's Russian Cancer Research Center | 2019-09-01 |
| Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer (NCT04103697) | Blokhin's Russian Cancer Research Center | 2019-08-01 |
| FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (NCT04393584) | Blokhin's Russian Cancer Research Center | 2019-01-29 |